Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mastocytosis × AK002 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mastocytosis, Systemic 1 Mastocytosis 1

Interventions

masitinib 4 Imatinib Mesylate 2 midostaurin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Stem Cell Transplantation 1 Single-Cell Gene Expression Analysis 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Injections 1 Dasatinib 1 Cyclophosphamide 1 Cromolyn Sodium 1 Cladribine 1 Busulfan 1 AK002 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02808793 2019-03-13

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Allakos Inc.

Phase 1 Completed

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡